Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of in situ self-assembled polypeptide derivatives in response to pathological microenvironment and its application

A technology of peptide derivatives and microenvironment, applied in the field of biomedicine, can solve problems such as the non-universality of tumor cells, long-term toxicity of nanomaterials, drug leakage, etc., achieve strong cancer cell killing effect, enhance retention, and reduce toxic and side effects Effect

Active Publication Date: 2022-08-09
INST OF RADIATION MEDICINE CHINESE ACADEMY OF MEDICAL SCI
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, although polymer micelles containing small molecule ferroptosis inducers and the amorphous calcium carbonate composite nanomedicine disclosed in CN111228513A can effectively reverse drug resistance or further kill tumor cells by inducing ferroptosis, there are drug leakage and toxicity. risk of side effects
Although manganese-silicon nanobubbles with GSH depletion ability can realize the diagnosis and treatment of tumors at the same time, they can only target arginine succinate synthase-deficient tumor cells, and are not universally applicable to tumor cells
In addition, nanomaterials remaining in the body may have long-term toxicity risks, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of in situ self-assembled polypeptide derivatives in response to pathological microenvironment and its application
  • A kind of in situ self-assembled polypeptide derivatives in response to pathological microenvironment and its application
  • A kind of in situ self-assembled polypeptide derivatives in response to pathological microenvironment and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1 2

[0050] Example 1 Synthesis of disulfide linker Fmoc-CS (compound of formula II)

[0051] In a 250mL round-bottom flask, add cystamine dihydrochloride (2.25g, 10mmol), NaHCO 3 (2.52 g, 30 mmol), 1,4-dioxane (35 mL), and an appropriate amount of water (50 mL), and then added with magnetic stirring, after the solution became clear, added succinic anhydride (1 g, 10 mmol), and stirred overnight.

[0052] Continue adding NaHCO to the round bottom flask 3 (840 mg), a mixed solution of Fmoc-OSu (3.37 g, 10 mmol) and acetone (25 mL) was added dropwise, and stirring was continued overnight.

[0053] Use a high-speed centrifuge to centrifuge (10000rpm, 5min) to collect the supernatant, remove the organic solvent by rotary evaporation, then add about 200mL of water to mix, and then adjust the pH to 2-3 with 1M HCl, a white product is precipitated, and the white solid is collected by filtration , freeze-dried using a freeze dryer, and the result is the product.

Embodiment 2

[0054] Example 2 Polypeptide derivative Nap- with side chain protected disulfide bond D F D Synthesis of FY-CS-DEVD(tBu) (the compound of formula III)

[0055] Weigh 0.5 g of dichloro resin into a solid-phase synthesis tube, add about 10 mL of dichloromethane (DCM), place the solid-phase synthesis tube on a shaking table to swell for 5 minutes, and squeeze out the solvent in the tube with an ear-washing ball. Weigh 0.5 mmol of the first amino acid Fmoc-Asp(OtBu)-OH into a 20 mL vial, add about 10 mL of DCM, and then add 1 mmol (200 μL) DIEA, pipette with a plastic dropper to dissolve it completely, and then add it to the solution. In a solid-phase synthesis tube, the reaction was carried out at room temperature for 2 h. After the reaction, the reaction solution was extruded, washed twice with DCM and three times with N,N-dimethylformamide (DMF), and about 10 mL of freshly prepared methanol solution (DCM:CH) was added. 3 OH:DIEA=17:2:1), to block the unreacted active chlorin...

Embodiment 3

[0056] Example 3 Synthesis of BSO (compound of formula IV) whose amino group is protected by Fmoc

[0057] In a 100 mL eggplant flask, add butthionine sulfoximine (1.11 g, 5 mmol) and NaHCO 3 (840 mg, 10 mmol), dissolved in an appropriate amount of water, and cooled to 0°C. Fmoc-OSu (1.69 g, 5 mmol) was dissolved in 1,4-dioxane (20 mL), added dropwise to the above system, reacted in ice bath for 1 h, and then reacted at room temperature for 3 h. After the reaction was completed, poured into 200 mL of water, extracted twice with ether, adjusted the pH to about 2 with 1M HCl, extracted three times with ethyl acetate, evaporated to remove the solvent, and lyophilized.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of biomedicine, and specifically discloses an in-situ self-assembled polypeptide derivative responsive to a pathological microenvironment and an application thereof. The polypeptide derivative has the structure shown in formula (I), wherein: R 1 stands for commonly used amino acid capping, R 2 and R 3 represents the same or different hydrophilic amino acid side chains. The polypeptide derivatives can realize the shape conversion of nanospheres to nanofibers through GSH response, enhance the retention of drugs in tumor cells, reduce toxic side effects, and improve safety; and have the ability to induce ferroptosis in tumor cells, thereby producing strong It can be used for anticancer therapy and guide the synthesis of ferroptosis inducers, and has a good application prospect. In addition, the polypeptide derivative provided by the present invention also has the function of fluorescence imaging, so that it also has a broad application prospect in fluorescence imaging.

Description

technical field [0001] The invention relates to the technical field of biomedicine, in particular to an in-situ self-assembled polypeptide derivative responsive to a pathological microenvironment. Background technique [0002] Cancer has become a major global public health problem with increasing morbidity and mortality. At present, the main treatment methods for cancer include surgery, chemotherapy, radiotherapy, immunotherapy, etc. However, these commonly used treatment methods also have some drawbacks, such as easy recurrence of surgery, radiotherapy due to radiation resistance, which makes the effect of radiotherapy unsatisfactory, chemotherapy due to drugs Poor selectivity can bring serious side effects. Therefore, emerging cancer treatment modalities such as biological therapy, photodynamic therapy, and photothermal therapy are also emerging. [0003] Ferroptosis is a new type of programmed cell death caused by the accumulation of iron-dependent lipid peroxides, whic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K7/06C07K1/06C07K1/04C07K1/02A61K38/08A61P35/00
CPCC07K7/06A61P35/00A61K38/00Y02P20/55
Inventor 刘鉴峰杨翠红高阳刘金剑黄帆任春华杨丽军张玉民
Owner INST OF RADIATION MEDICINE CHINESE ACADEMY OF MEDICAL SCI